Description: Diagonal Bio AB (publ) operates as a biotechnology company in Sweden. It is involved in developing the Panviral platform for detecting and diagnosing small sections of pathogen genomes, such as viruses, bacteria, and fungi. The company was incorporated in 2020 and is headquartered in Lund, Sweden.
Home Page: diagonalbio.com
The Spark
Lund,
223 81
Sweden
Phone:
46 7 35 26 27 59
Officers
| Name | Title |
|---|---|
| Mr. Jack Egelund Madsen | Chief Exec. Officer |
| Mr. Andreas Nyberg | Founder & Chief Scientific Officer |
| Mr. Kushagr Punyani | Tech Advisor, Founding Partner & Director |
| Mr. Johan Kallstrand | Founding Partner |
| Mr. Per Heander | Chief Financial Officer |
Exchange: ST
Country: SE
Currency: Swedish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4971 |
| Price-to-Sales TTM: | 3.2648 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 6 |